IFM just crossed fifty percent in Atlas Arteria on the open market — which means the one clean, dated price signal I've been begging for all week is now controlled by the very buyer setting it. This is Infrastructure Secondaries Daily. Today — a hostile bid gives us a live ASX price, then immediately complicates it, plus a twenty-billion-dollar pension handoff that quietly moves who signs the election form. Follow the show and the next briefing lands in your feed on its own. Here's Riddhima Talwani at Financial Standard:
Last week, IFM had raised its stake in Atlas Arteria from 34.5% to 38.3%, just a day after it raised its offer price for the toll road operator to $5.10 per security. This week, IFM increased its stake from 38.3% to 40.7%, before lifting it to 45.6%. It has now acquired further shares today, taking its direct stake in the toll-road operator to 50.1%.
IFM is now at 50.1% direct, 52.3% all-in, on Atlas Arteria — and it got there by buying on-market, with reportable crossing dates. That's the live, timestamped price signal I've been chasing all week: a specific ASX security, a sequence of purchases, and an offer that moved from A$4.95 in April to A$5.10 last week. Right — but watch what just happened to that signal. Once a single buyer creeps to majority through the open market, the share price isn't an independent read anymore. It's IFM's read. Exactly. People want to wave the listed price around as a clean benchmark against fund NAVs. A share price inside a still-contested bid is its own kind of stale — strategically managed at both ends. And the 50% cross automatically triggered a 14-day extension to the closing deadline, per Grafa. So the same move that got IFM control also bought them more runway to keep buying. Funny how that works for the controlling party and not the seller. Meanwhile, Atlas is offloading the German Warnow Tunnel to Eiffage under a four-week exclusivity window, while it's still working the Chicago Skyway divestment. The asset base is moving under the bid. Which is the part nobody prices cleanly. You're marking a company whose own portfolio is mid-sale, while the buyer controls the float. Tell me again how that A$7.4 billion number is gospel. So IFM just crossed 50% ownership in Atlas Arteria through on-market purchases. But if we've got a live share price on an ASX-listed company, shouldn't that be a cleaner read on value than whatever a fund administrator puts in a quarterly NAV? Cleaner than a stale NAV? Sometimes. But Atlas is a pretty good reminder that “listed” doesn't always mean “settled.” IFM launched the hostile bid in late April at A$6.9 billion — roughly $4.95 per security — then raised it to a best-and-final $5.10, valuing the company at around A$7.4 billion, per Financial Standard's June 15th reporting. Atlas Arteria's board brought in Kroll, and Kroll said the offer is “neither fair nor reasonable.” Its range is $5.39 to $6.20 per security, meaning even the floor sat about a billion dollars above what IFM is paying. IFM fired back, calling Kroll's analysis “unbalanced and based on unreasonable assumptions.” So secondary buyers have to hold three marks in their head at once: the on-market share price IFM has been buying at, the offer price, and Kroll's DCF range. They miss each other by roughly $1 billion at the midpoint. If you're using listed comps to pressure-test fund NAVs, that's the warning label: a public price in a contested takeover reflects the bid premium and market expectations of a higher offer, not necessarily the stabilized long-run asset value. If IFM is already above 50% and still buying, does that settlement question even matter anymore — or does majority control just settle the price debate by fait accompli? Majority control settles governance. Valuation is messier: minority shareholders who didn't tender still have legal avenues, and the Kroll opinion stays on the record as a documented challenge to the price paid. For secondary practitioners, the number to watch is whether IFM ultimately compulsory-acquires the remaining shares, and at what price. That final squeeze-out level becomes the closest thing to a court-tested mark on a global toll-road portfolio of this scale. From Gavin Lumsden at QuotedData:
It said its offer was dependent on it establishing a consortium of pension schemes to create a world-class venture capital platform around IP Group, which it said “plays a strategically vital role in the UK economy”. IP Group this afternoon rejected the offer saying it “materially undervalued” the company at a 37% discount to its 110.4p NAV per share at 31 December and pointing out its shares had stood at 70.6p earlier this month.
Here's the flip I keep waiting for. Railpen — the £34 billion railways scheme — is trying to step into the GP role instead of getting squeezed by one. An 18.4% holder bidding to take IP Group private and run it as a captive VC platform for pension money. And IP Group said no this afternoon — called the 69.7p offer a material undervaluation. Which, fine, but notice the rationale Railpen leaned on: the persistent discount to NAV. Right, the discount is the pitch. “You've traded below NAV for years, let us fix that by taking you out.” The board's answer is that the bid itself prices below what they think it's worth — so now you've got two NAV claims pointing in opposite directions and a buyer who's also a shareholder. And that's the part that should bother anyone who cares about a clean fairness process. If Railpen had won, who's the independent arbiter? The buyer is the scheme's own capital. There's no obvious neutral seat at that table. The board protected the incumbent, this time. The interesting question is whether LP-to-manager consolidation ever gets traction, or whether listed-company governance just reflexively says no. One rejection doesn't make a trend, but finally, we have a real test case. Joseph N. DiStefano, writing in The Philadelphia Inquirer:
In one of the biggest outsourcing moves in Pennsylvania investment history, the board of the $84 billion-asset state teachers’ pension plan, PSERS, voted last week to outsource investments worth $20 billion to BNY Investments Mellon, replacing work now done by members of PSERS investment staff.
PSERS just voted to hand $20 billion to BNY Mellon — that's roughly a quarter of an $84 billion fund moving out the door of the internal team and onto an outsourced desk. Cotton's pitch is that index fees fell and outside managers got better at tracking benchmarks. Fine for the public-equity sleeve. But what I want to know is what happens to the illiquid infra tail when somebody new starts rationalizing the book. And here's the governance piece nobody's saying out loud: if PSERS holds infra fund stakes, and discretion now sits with an outsourced CIO — who signs the election form on a GP-led continuation vehicle? SEC Rule 211(h)(2)-2 says the independent fairness opinion has to reach the decision-maker before the deadline. That timing rule was written for an in-house LP team. Slide a third party into the chain and “the decision-maker” gets genuinely murky. Right — and a pension under political and liquidity pressure for years outsourcing a quarter of its assets is a fund admitting its internal diligence couldn't keep pace. Who prices PSERS's existing private infra positions now, and on whose timeline? If you track capital flows, try Startup Fundraising: daily AI startup funding rounds, seed and Series A deals, new VC funds, and notable founders. It's a useful companion for seeing where private-market momentum is building. Find it wherever you listen to podcasts.
What we're watching next: Eiffage now has a four-week exclusivity window to conduct due diligence and negotiate terms for Atlas Arteria's potential sale of the Warnow Tunnel.
You'll find links to all the stories we covered today in the show notes, so if one deserves a closer read, that's the place to start.
That's Infrastructure Secondaries Daily for today. This is a Lantern Podcast.